Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Vulvar Neoplasms × cemiplimab × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 7 Neoplasm Metastasis 2 Lung Neoplasms 2 Vulvar Neoplasms 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Recurrence 1 Rectal Neoplasms 1 Penile Neoplasms 1 Neoplasms 1 Mesothelioma, Malignant 1 Gliosarcoma 1 Glioblastoma 1 Disease Progression 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Merkel Cell 1 Carcinoma 1 Advanced Squamous Non-Small Cell Lung Cancer 1 Adenocarcinoma 1

Interventions

Indocyanine Green 2 zimberelimab 1 pembrolizumab 1 lenvatinib 1 fludarabine 1 cemiplimab 1 RNA 1 DNA 1 Cyclophosphamide 1 Circulating Tumor DNA 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07101848 2025-08-03

BRAVA VULVAR

Hospital Israelita Albert Einstein

Phase 2 Not yet recruiting

Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡